1[1]Bean WJ, Kawaoka YM, Wood JM, et al. Characterization of virulent and avirulent A/Chicken/Pennsylvania/83 influenza A viruse[J]. J. Virol., 1985,53:151-160.
2[2]Wood JM, Kawaoka Y, Newberry LA, et al. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal[J]. Avian Dis., 1985,29:867-872.
3[3]Garcia A, Johnson H, Srivastava DK, et al. Efficacy of inactivated H5N2influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection[J].Avian Dis., 1998, 42: 248-256.
4[4]Brugh M, Beard CW and Stone HD. Immunization of chickens and turkeys against avian influenza with monovalent and polyvalent oil emuls ion vaccines [J]. Am. J. Vet. Res., 1979, 40: 165-169.
5[5]Deroo T, Min Jou W and Fiers W. Recombinant neuraminidase vaccine protects against lethal in fluenza[J]. Vaccine, 1996, 14(6): 561-569.
6[6]Fatunmbi OO and Newman JA. Enhancement of immune response of turkeys to trivalent avian influenza vaccine by positively charged lipo-somal avridine adjuvant[J]. Vaccine, 1992, 10(2): 623-626.
7[7]Fatunmbi OO, Newman JA and Sivanandan V. Efficacy of avridine and liposomes as adiuvants for avian influenza virus against in turkeys[J]. Avian.Pathol, 1992, 21(2): 225-227.
8[8]Perkins FT, Regamey RH. Proceedings of an international symposium on influenza vaccines for men and horses[C]. London, November 1972. Symposia Series in Immunobiological Standardization.
9[9]Schild GC, Wood JM, Newman RW. A single-radial-immunodion technique for the assay of influenza haemagglutinin antigen[R]. Bull. WHO. 1975,52: 223-231.
10[10]Ennis FA, Mayner RE, and Barry DW. Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines[J]. J. Infect Dis., 1977, 136: 397-406.
